Company Filing History:
Years Active: 2007
Title: Mary-Margaret E O'Donnell: Innovator in Pharmaceutical Compounds
Introduction
Mary-Margaret E O'Donnell is a notable inventor based in Shelton, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can modulate MCH binding to MCH receptors. Her work is essential for addressing various metabolic, feeding, and sexual disorders in both humans and animals.
Latest Patents
Mary-Margaret holds a patent for "Substituted 1-benzyl-4-substituted piperazine analogues." This patent includes compounds of Formula I, which are designed to be used in vivo or in vitro. These compounds are particularly useful in treating a variety of disorders and include pharmaceutical compositions and methods for detecting MCH receptors.
Career Highlights
Mary-Margaret is associated with Neurogen Corporation, where she has been instrumental in advancing research and development in her field. Her innovative approach has led to the creation of valuable pharmaceutical solutions.
Collaborations
She has collaborated with notable colleagues such as Alan J Hutchison and Bertrand Leo Chenard, contributing to a dynamic research environment that fosters innovation.
Conclusion
Mary-Margaret E O'Donnell's work exemplifies the impact of innovation in the pharmaceutical industry. Her contributions continue to pave the way for advancements in treating complex disorders.